BlackRock’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-17,794,654
| Closed | -$824M | – | 5172 |
|
|
2019
Q2 | $824M | Buy |
17,794,654
+771,477
| +5% | +$21.7M | 0.04% | 503 |
|
|
2019
Q1 | $415M | Buy |
17,023,177
+60,977
| +0.4% | +$1.27M | 0.02% | 861 |
|
|
2018
Q4 | $242M | Sell |
16,962,200
-159,052
| -0.9% | -$2.41M | 0.01% | 1174 |
|
|
2018
Q3 | $260M | Buy |
17,121,252
+201,556
| +1% | +$3.09M | 0.01% | 1276 |
|
|
2018
Q2 | $284M | Buy |
16,919,696
+970,259
| +6% | +$15.4M | 0.01% | 1162 |
|
|
2018
Q1 | $260M | Buy |
15,949,437
+696,635
| +5% | +$11.2M | 0.01% | 1155 |
|
|
2017
Q4 | $195M | Buy |
15,252,802
+1,707,369
| +13% | +$19.4M | 0.01% | 1403 |
|
|
2017
Q3 | $167M | Buy |
13,545,433
+550,733
| +4% | +$5.12M | 0.01% | 1504 |
|
|
2017
Q2 | $109M | Buy |
12,994,700
+125,563
| +1% | +$1.03M | 0.01% | 1739 |
|
|
2017
Q1 | $115M | Buy |
12,869,137
+12,835,602
| +38,275% | +$137M | 0.01% | 1687 |
|
|
2016
Q4 | $294K | Sell |
33,535
-967
| -3% | -$7.12K | ﹤0.01% | 1919 |
|
|
2016
Q3 | $233K | Buy |
34,502
+848
| +3% | +$3.28K | ﹤0.01% | 2074 |
|
|
2016
Q2 | $120K | Buy |
33,654
+24,349
| +262% | +$79.3K | ﹤0.01% | 2427 |
|
|
2016
Q1 | $27K | Buy |
9,305
+1,647
| +22% | +$4.93K | ﹤0.01% | 2705 |
|
|
2015
Q4 | $33K | Buy |
7,658
+4,200
| +121% | +$19.2K | ﹤0.01% | 2307 |
|
|
2015
Q3 | $16K | Hold |
3,458
| – | – | ﹤0.01% | 2522 |
|
|
2015
Q2 | $25K | Sell |
3,458
-377
| -10% | -$2.78K | ﹤0.01% | 2303 |
|
|
2015
Q1 | $28K | Sell |
3,835
-288,200
| -99% | -$2.05M | ﹤0.01% | 2209 |
|
|
2014
Q4 | $1.38M | Hold |
292,035
| – | – | ﹤0.01% | 1137 |
|
|
2014
Q3 | $1.04M | Sell |
292,035
-22,922
| -7% | -$90.4K | ﹤0.01% | 1199 |
|
|
2014
Q2 | $1.44M | Sell |
314,957
-377
| -0.1% | -$1.56K | ﹤0.01% | 1124 |
|
|
2014
Q1 | $1.48M | Buy |
315,334
+322
| +0.1% | +$1.62K | ﹤0.01% | 1106 |
|
|
2013
Q4 | $1.58M | Buy |
315,012
+311,312
| +8,414% | +$1.69M | ﹤0.01% | 1072 |
|
|
2013
Q3 | $23K | Hold |
3,700
| – | – | ﹤0.01% | 2212 |
|
|
2013
Q2 | $17K | Buy |
+3,700
| New | +$19.9K | ﹤0.01% | 2389 |
|
Other funds holding ARRY
BlackRock's ARRY Position: Q3 2019 in Review
BlackRock sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 17,794,654 shares — an estimated $824M sold.
BlackRock first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $824M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- BlackRock reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- BlackRock sold 17,794,654 Array Biopharma Inc shares in Q3 2019, an estimated $824M.
- BlackRock first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
- BlackRock's Array Biopharma Inc position peaked at $824M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on BlackRock's 13F filing for Q3 2019, filed 8 Nov 2019.